Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Sino Biopharmaceutical’s Limaprost Approved by NMPA for Lumbar Spinal Stenosis Treatment
January 18, 2025
Company
R&D
Biocytogen’s ‘Nano 100 Project’ Aims to Develop Over 100 Fully Human Nanobody Drugs
January 18, 2025
Company
Deals
Suzhou Porton Biologics Partners with Yinjia Biosciences for CGT Development
January 18, 2025
Company
Drug
Biosyngen’s BRG01 Gets FDA Nod for NPC Clinical Study
January 18, 2025
Policy / Regulatory
CDE Issues Guidelines for Real-World Drug Research and Evidence Framework
January 18, 2025
Company
Policy / Regulatory
China’s 8th Volume-Based Procurement Round Begins Drug Info Filing
February 2, 2025
Company
Drug
BRL Medicine Achieves First Cure of Thalassemia Major with BRL-101
January 18, 2025
Company
Drug
Immuno Cure BioTech Launches Phase I HIV/AIDS Vaccine Study
January 18, 2025
Company
Deals
Clover Biopharmaceuticals Secures Exclusive Deal for AdimFlu-S Distribution in China
January 18, 2025
Company
Deals
Hainan Honz Partners with GPI for Pediatric and Maternity Medicine Expansion
January 18, 2025
Company
Deals
MoleculeMind Raises Over RMB 100 Million for AI Protein Design Platform
January 18, 2025
Drug
Policy / Regulatory
Zhejiang Suspends Generic Nesina Trading Due to IP Disputes
January 18, 2025
1
2
…
1,028
1,029
1,030
1,031
1,032
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?